Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of -0.73% is 95% above its 5-year average of -15.34%, near the high end of its 5-year range (-45.74%–2.35%).
60.26% above its 12-month average of -1.84%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): -3.23%.
OPERATING MARGIN
-0.73%
OPERATING MARGIN AVG TTM
-1.84%
OPERATING MARGIN AVG 3Y
-7.54%
OPERATING MARGIN AVG 5Y
-15.34%
OPERATING MARGIN AVG 10Y
-54.84%
OPERATING MARGIN AVG 15Y
-70.35%
OPERATING MARGIN AVG 20Y
-82.17%
CURRENT VS TTM AVG
+60.26%
CURRENT VS 3Y AVG
+90.32%
CURRENT VS 5Y AVG
+95.24%
CURRENT VS 10Y AVG
+98.67%
CURRENT VS 15Y AVG
+98.96%
CURRENT VS 20Y AVG
+99.11%
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 496 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Cerus Corporation
Market Cap
$471.57M
Operating Margin
-0.73%
TTM Avg
-1.84%
3Y Avg
-7.54%
5Y Avg
-15.34%
Market Cap
$478.54M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
-8.04%
5Y Avg
-6.43%
Market Cap
$481.33M
Operating Margin
-43.75%
TTM Avg
-69.37%
3Y Avg
-212.63%
5Y Avg
-278.07%
Market Cap
$487.30M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$453.70M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$491.55M
Operating Margin
-8.63%
TTM Avg
-11.52%
3Y Avg
-18.04%
5Y Avg
-16.64%
Market Cap
$491.93M
Operating Margin
-7.33%
TTM Avg
-12.79%
3Y Avg
-23.47%
5Y Avg
-68.20%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Cerus Corporation (CERS) | $471.57M | -0.73% | -1.84% | -7.54% | -15.34% |
| NRC Health (NRC)vs › | $468.31M | 10.53% | 20.52% | 24.67% | 27.45% |
| Contineum Therapeutics, Inc. (CTNM)vs › | $478.54M | 0.00% | 0.00% | -8.04% | -6.43% |
| Arvinas, Inc. (ARVN)vs › | $481.33M | -43.75% | -69.37% | -212.63% | -278.07% |
| Kamada Ltd. (KMDA)vs › | $461.55M | 14.51% | 13.50% | 9.39% | 8.55% |
| Bright Minds Biosciences Inc. (DRUG)vs › | $487.30M | 0.00% | 0.00% | 0.00% | 0.00% |
| DiaMedica Therapeutics Inc. (DMAC)vs › | $453.70M | 0.00% | 0.00% | 0.00% | 0.00% |
| NeoGenomics, Inc. (NEO)vs › | $491.55M | -8.63% | -11.52% | -18.04% | -16.64% |
| Evolus, Inc. (EOLS)vs › | $491.93M | -7.33% | -12.79% | -23.47% | -68.20% |
| Assembly Biosciences, Inc. (ASMB)vs › | $450.64M | -11.75% | -88.01% | -269.63% | -547.01% |
Gross Margin
52.0%
Operating Margin
-0.7%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | -3.23% |
| 2026-03-31 | -0.66% |
| 2025-12-31 | -1.11% |
| 2025-09-30 | 2.35% |
| 2025-06-30 | -6.53% |
| 2025-03-31 | -13.54% |
| 2024-12-31 | -2.85% |
| 2024-09-30 | -2.09% |
| 2024-06-30 | -8.51% |
| 2024-03-31 | -20.80% |
| 2023-12-31 | 2.09% |
| 2023-09-30 | -13.18% |
| 2023-06-30 | -29.96% |
| 2023-03-31 | -45.67% |
| 2022-12-31 | -22.60% |
| 2022-09-30 | -18.82% |
| 2022-06-30 | -16.67% |
| 2022-03-31 | -26.30% |
| 2021-12-31 | -17.46% |
| 2021-09-30 | -30.79% |
| 2021-06-30 | -45.74% |
| 2021-03-31 | -70.35% |
| 2020-12-31 | -50.86% |
| 2020-09-30 | -59.23% |
| 2020-06-30 | -67.93% |
| 2020-03-31 | -82.76% |
| 2019-12-31 | -78.44% |
| 2019-09-30 | -94.11% |
| 2019-06-30 | -92.22% |
| 2019-03-31 | -91.80% |
| 2018-12-31 | -93.54% |
| 2018-09-30 | -88.34% |
| 2018-06-30 | -81.52% |
| 2018-03-31 | -98.46% |
| 2017-12-31 | -66.82% |
| 2017-09-30 | -114.68% |
| 2017-06-30 | -170.12% |
| 2017-03-31 | -258.25% |
| 2016-12-31 | -149.18% |
| 2016-09-30 | -140.14% |
| 2016-06-30 | -180.94% |
| 2016-03-31 | -201.06% |
| 2015-12-31 | -155.27% |
| 2015-09-30 | -201.19% |
| 2015-06-30 | -175.82% |
| 2015-03-31 | -186.83% |
| 2014-12-31 | -132.05% |
| 2014-09-30 | -109.54% |
| 2014-06-30 | -127.94% |
| 2014-03-31 | -117.20% |
| 2013-12-31 | -84.55% |
| 2013-09-30 | -79.92% |
| 2013-06-30 | -70.03% |
| 2013-03-31 | -50.96% |
| 2012-12-31 | -34.18% |
| 2012-09-30 | -52.48% |
| 2012-06-30 | -52.03% |
| 2012-03-31 | -52.06% |
| 2011-12-31 | -34.43% |
| 2011-09-30 | -28.61% |
| 2011-06-30 | -81.10% |
| 2011-03-31 | -63.63% |
| 2010-12-31 | -73.52% |
| 2010-09-30 | -74.21% |
| 2010-06-30 | -59.76% |
| 2010-03-31 | -69.14% |
| 2009-12-31 | -89.73% |
| 2009-09-30 | -124.91% |
| 2009-06-30 | -130.22% |
| 2009-03-31 | -213.04% |
| 2008-12-31 | -197.55% |
| 2008-09-30 | -195.29% |
| 2008-06-30 | -227.20% |
| 2008-03-31 | -133.43% |
| 2007-12-31 | 314.45% |
| 2007-09-30 | -283.38% |
| 2007-06-30 | -418.94% |
| 2007-03-31 | -168.07% |
| 2006-12-31 | 15.16% |
| 2006-09-30 | -33.89% |
| 2006-06-30 | -91.95% |
| 2006-03-31 | -42.63% |
| 2005-12-31 | -59.68% |
| 2005-09-30 | -27.72% |
| 2005-06-30 | -55.05% |
| 2005-03-31 | -16.70% |
| 2004-12-31 | -148.29% |
| 2004-09-30 | -114.04% |
| 2004-06-30 | -274.51% |
| 2004-03-31 | -221.11% |
| 2003-12-31 | -255.97% |
| 2003-09-30 | -457.43% |
| 2003-06-30 | -777.43% |
| 2003-03-31 | -1270.37% |
| 2002-12-31 | -1002.61% |
| 2002-09-30 | -2339.18% |
